Author Archives: xmla

GMP manufacturing 101

Cell and tissue-based therapies are manufactured in a laboratory setting for the subsequent implantation into... Read More.

How to improve R&D outcomes, standards, techniques, & knowledge.

R&D outcomes depend heavily on a variety of factors, some which are under the direct... Read More.

COVID-19 and any development and ongoing clinical trials to treat it using regenerative medicine

The recent COVID-19 pandemic has sparked the opportunity for regenerative medicine to help find therapeutic... Read More.

The Global approach to cell therapy and the future

Regenerative medicine has witnessed unprecedented growth as a result of cell-based therapies for the treatment... Read More.

Culture Media

It is imperative to obtain the right culture media for your intended cellular use. Several... Read More.

Assays development for analyzing the potency of cells (MSCs)

Mesenchymal stem cells (MSCs) are multipotent cells that can be derived from a variety of... Read More.

Research and understanding Extracellular vesicles

Extracellular vesicles (EVs) are lipid enclosed particles that are naturally released by cells. EVs have... Read More.

Car T and iPSC cells

Regenerative medicine has produced remarkable therapies for tackling diseases that have eluded effective treatment. Chimeric... Read More.

Regenerative medicine and our milestone when it comes to R&D and accomplishments

The potential of regenerative medicine lies in its integration of different fields, such as engineering... Read More.